A VE-VCO2 slope ≥28.42 during cardiopulmonary exercise testing independently predicted a higher risk of acute exacerbations in patients with chronic obstructive pulmonary disease (HR 3.18).
Cohort
No
Does an elevated VE-VCO2 slope during Cardiopulmonary Exercise Test predict acute exacerbations of COPD in clinically stable patients?
79 patients with chronic obstructive pulmonary disease (COPD) aged 40-85 years, mean age 66.6, 86.1% male, based in China. Key inclusion: GOLD diagnostic confirmation (post-bronchodilator FEV1/FVC <0.70) and clinically stable status. Key exclusion: cardiac morbidities (heart failure, arrhythmias, valvulopathies, or coronary artery disease), use of β-blocker/outcome-interfering medication, hypoxemia requiring supplemental oxygen, and physical limitations contraindicating CPET.
Cardiopulmonary Exercise Test (CPET) with measurement of VE-VCO2 slope, specifically evaluating a high-risk stratification of VE-VCO2 slope ≥ 28.42.
Low-risk stratification with VE-VCO2 slope < 28.42.
Occurrence of acute exacerbation of COPD (AECOPD), defined as the emergence of frequent respiratory symptoms and the need for hospitalization and additional outpatient treatments, over a 5-year follow-up period.hard clinical
A VE-VCO2 slope ≥ 28.42 during cardiopulmonary exercise testing serves as a strong, independent predictor of acute exacerbations in patients with COPD over a 5-year period.
Background: Cardiopulmonary Exercise Test (CPET) serves as an integrative assessment tool to evaluate cardiac function, respiratory responses, and neuromuscular capacity in patients with chronic obstructive pulmonary disease (COPD) during incremental cycling exercise. VE-VCO2 slope during CPET was not fully understood in predicting acute exacerbations of COPD (AECOPD). This study aims to establish a predictive model for AECOPD based on the VE-VCO2 slope. Methods: In total, 79 patients with COPD were recruited between 2013 and 2019. All participants underwent baseline pulmonary function tests and CPET and were followed up for 5 years thereafter. Independent two-sample t -tests and Chi-square tests were used to compare AECOPD and Non-AECOPD groups. Univariate and multivariate Cox regression analyses were utilized to identify predictive factors for AECOPD. The diagnostic performance of these variables was evaluated by receiver operating characteristic (ROC) curve analysis. The optimal cutoff values calculated by Youden’s index. Kaplan-Meier survival analysis between subgroups was based on the optimal cutoff values. Generating Forest plots to visualize Cox regression analysis results. Results: The AECOPD group contains 62 participants and the Non-AECOPD group contains 17 participants. Groups comparisons revealed significant differences in VE-VCO2 slope, age, BMI, FEV1%predicted, FEV1/FVC ratio, and EqCO2. Multivariate Cox regression analysis identified VE-VCO2 slope (OR = 1.19, 95% CI: 1.09– 1.29, p < 0.001), age (OR = 1.05, 95% CI: 1.02– 1.09, p = 0.005), and FEV1%predicted (OR = 0.96, 95% CI : 0.94– 0.99, p = 0.015) as significant predictors of AECOPD. The ROC curve analysis results about the above predictors found that the AUC of VE-VCO2 slope is highest independently in 1 year, 3 years and 5 years, with the optimal cutoff values = 28.42 in 5 years (hazard ratio = 3.18, 95% CI: 1.639– 6.2, p < 0.001). Conclusion: The stratification of VE-VCO2 slope ≥ 28.42 was an independent predictor of AECOPD. Our study established VE-VCO2 slope as a novel stratified clinical biomarker for predicting AECOPD. Keywords: COPD, exacerbation, CPET, VE-VCO2 slope, ventilation-perfusion mismatch
Building similarity graph...
Analyzing shared references across papers
Loading...
Xiaona Li
Fang Lin
Jingxuan Wu
International Journal of COPD
Beijing Friendship Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Li et al. (Sun,) conducted a cohort in Chronic Obstructive Pulmonary Disease (COPD) (n=79). VE-VCO2 slope ≥28.42 vs. VE-VCO2 slope <28.42 was evaluated on Acute exacerbations of COPD (AECOPD) (HR 3.18, 95% CI 1.64-6.20, p=<0.001). A VE-VCO2 slope ≥28.42 during cardiopulmonary exercise testing independently predicted a higher risk of acute exacerbations in patients with chronic obstructive pulmonary disease (HR 3.18).
www.synapsesocial.com/papers/69c8c2e4de0f0f753b39d5af — DOI: https://doi.org/10.2147/copd.s581813